These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 10097598

  • 1. Pulmonary vasoconstriction during lidocaine administration are modulated by endothelium-derived relaxing factor.
    Hayashi M.
    Osaka City Med J; 1998 Dec; 44(2):181-94. PubMed ID: 10097598
    [Abstract] [Full Text] [Related]

  • 2. [Vasoactive intestinal peptide (VIP)-induced pulmonary vasodilation mediated by EDRF/NO in isolated perfused rat lungs].
    Iwabuchi S, Ono S, Funata J, Hoshikawa Y, Ueda S, Ashino Y, Tanita T, Fujimura S, Koike K.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Mar; 33(3):262-7. PubMed ID: 7739167
    [Abstract] [Full Text] [Related]

  • 3. Lidocaine-induced hemodynamic effects are enhanced by the inhibition of endothelium-derived relaxing factor in dogs.
    Toyoyama H, Yukioka H, Hayashi M, Tatekawa S, Fujimori M.
    Acta Anaesthesiol Scand; 1997 Jun; 41(6):766-73. PubMed ID: 9241340
    [Abstract] [Full Text] [Related]

  • 4. Role of nitric oxide in vasopressinergic pulmonary vasodilatation.
    Russ RD, Walker BR.
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H743-7. PubMed ID: 1558183
    [Abstract] [Full Text] [Related]

  • 5. L-NAME enhances pulmonary vasoconstriction without inhibiting EDRF-dependent vasodilation.
    Lippton HL, Hao Q, Hyman A.
    J Appl Physiol (1985); 1992 Dec; 73(6):2432-9. PubMed ID: 1490955
    [Abstract] [Full Text] [Related]

  • 6. Endothelium-derived relaxing factor inhibits constrictor responses of large cerebral arteries to serotonin.
    Faraci FM, Heistad DD.
    J Cereb Blood Flow Metab; 1992 May; 12(3):500-6. PubMed ID: 1569143
    [Abstract] [Full Text] [Related]

  • 7. EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs.
    Oka M, Hasunuma K, Webb SA, Stelzner TJ, Rodman DM, McMurtry IF.
    Am J Physiol; 1993 Jun; 264(6 Pt 1):L587-97. PubMed ID: 8333550
    [Abstract] [Full Text] [Related]

  • 8. EDRF and norepinephrine-induced vasodilation in the canine coronary circulation.
    Van Bibber R, Traub O, Kroll K, Feigl EO.
    Am J Physiol; 1995 May; 268(5 Pt 2):H1973-81. PubMed ID: 7771547
    [Abstract] [Full Text] [Related]

  • 9. N omega-nitro-L-arginine and pulmonary vascular pressure-flow relationship in conscious dogs.
    Nishiwaki K, Nyhan DP, Rock P, Desai PM, Peterson WP, Pribble CG, Murray PA.
    Am J Physiol; 1992 May; 262(5 Pt 2):H1331-7. PubMed ID: 1590434
    [Abstract] [Full Text] [Related]

  • 10. Effects of oxygen and exogenous L-arginine on EDRF activity in fetal pulmonary circulation.
    McQueston JA, Cornfield DN, McMurtry IF, Abman SH.
    Am J Physiol; 1993 Mar; 264(3 Pt 2):H865-71. PubMed ID: 8456989
    [Abstract] [Full Text] [Related]

  • 11. Effects of lidocaine on pulmonary circulation during hyperoxia and hypoxia in the dog.
    Yukioka H, Hayashi M, Tatekawa S, Fujimori M.
    Reg Anesth; 1996 Mar; 21(4):327-37. PubMed ID: 8837191
    [Abstract] [Full Text] [Related]

  • 12. Evidence for the role of endothelium-derived relaxing factor in acetylcholine-induced vasodilatation in the intact lung.
    Cherry PD, Gillis CN.
    J Pharmacol Exp Ther; 1987 May; 241(2):516-20. PubMed ID: 3494839
    [Abstract] [Full Text] [Related]

  • 13. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
    El-Mas MM, Mohy El-Din MM, El-Gowilly SM, Sharabi FM.
    Eur J Pharmacol; 2004 Mar 08; 487(1-3):149-58. PubMed ID: 15033387
    [Abstract] [Full Text] [Related]

  • 14. Antagonists of EDRF attenuate acetylcholine-induced vasodilation in isolated hamster lungs.
    Tseng CM, Mitzner W.
    J Appl Physiol (1985); 1992 Jun 08; 72(6):2162-7. PubMed ID: 1629068
    [Abstract] [Full Text] [Related]

  • 15. Nitric oxide inhibits human and canine pulmonary vascular tone via a postjunctional, nonelectromechanical, cGMP-dependent pathway.
    Janssen LJ, Mardi K, Netherton S, Betti PA.
    Can J Physiol Pharmacol; 1999 May 08; 77(5):320-9. PubMed ID: 10535681
    [Abstract] [Full Text] [Related]

  • 16. The role of nitric oxide in the peripheral vasoconstriction caused by human placental lactogen in anaesthetized pigs.
    Molinari C, Grossini E, Mary DA, Ribichini F, Surico N, Vacca G.
    Exp Physiol; 2006 May 08; 91(3):603-10. PubMed ID: 16513823
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms influencing the vasoactive effects of lidocaine in human skin.
    Newton DJ, McLeod GA, Khan F, Belch JJ.
    Anaesthesia; 2007 Feb 08; 62(2):146-50. PubMed ID: 17223807
    [Abstract] [Full Text] [Related]

  • 18. [Role of nitric oxide in cholecystokinin octapeptide alleviation of tumor necrosis factor alpha induced changes in rabbit pulmonary arterial reactivity].
    Meng AH, Ling YL, Wang DH, Gu ZY, Li SJ, Zhu TN.
    Sheng Li Xue Bao; 2001 Dec 08; 53(6):478-82. PubMed ID: 11930230
    [Abstract] [Full Text] [Related]

  • 19. Nitric oxide blunts the endothelin-mediated pulmonary vasoconstriction in exercising swine.
    Houweling B, Merkus D, Dekker MM, Duncker DJ.
    J Physiol; 2005 Oct 15; 568(Pt 2):629-38. PubMed ID: 16081484
    [Abstract] [Full Text] [Related]

  • 20. Nitric oxide and prostaglandins mediate vasodilation to 5,6-EET in rabbit lung.
    Tan JZ, Kaley G, Gurtner GH.
    Adv Exp Med Biol; 1997 Oct 15; 407():561-6. PubMed ID: 9322008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.